Promising new results on the added safety of using SmokeStik® electronic cigarettes in the bid to quit smoking

Online, January 7, 2010 (Newswire.com) - In the summer of 2009 a smoking cessation pilot study was conducted to deliver more understanding to a multi- modal approach to quitting smoking safely and more effectively.
The aim of the pilot study was to examine overall cessation rates after 12 weeks in a multi-modal cessation program as well as test the safety of electronic cigarettes in terms of propylene glycol levels. This pilot represents a major first step in moving forward with a much larger randomised clinical trial testing whether the combination of multiple interventions has a positive effect on smoking cessation rates.
The current study combined 3 unique smoking cessation interventions; Varenicline, cognitive-behavioural group therapy and a SmokeStik® electronic cigarette.
At the end of the program all participants had quit smoking. Qualitative self-report data revealed that all participants found a multi-modal approach helpful in the smoking cessation process, including the use of an electronic cigarette. Smoking a pack a day equals 110,000 hand to mouth repetitions each year. A Smokestik® is a unique electronic cigarette simulation that helps you positively cope with this conditioned behaviour due to the device closely resembling the appearance of a cigarette.
Biological measures including lab tests conducted each month found negative blood levels of propylene glycol, and pre and post pulmonary function testing showed a marked improvement in participants overall lung functioning.
These results do suggest that multi-modal approaches may increase the chances of quitting smoking and that SmokeStik's electronic cigarettes appear safe with respect to the inhalation of propylene glycol. For further information on these trials please visit www.smokestik.com